I am very interested in EIQ, however, it looks like ultromics ( developed with oxford uni) has first in class advantage. Already has FDA approval. I am aware ultromics is initially interested mainly in heart failure, but only a matter of time to move onto AS. Does EIQ have any sig advantage over Ultromics?
Add to My Watchlist
What is My Watchlist?
 (20min delay)
|
|||||
|
Last
23.0¢ |
Change
-0.010(4.17%) |
Mkt cap ! $148.3M | |||
| Open | High | Low | Value | Volume |
| 24.5¢ | 24.5¢ | 22.5¢ | $281.9K | 1.212M |
Buyers (Bids)
| No. | Vol. | Price($) |
|---|---|---|
| 2 | 34622 | 23.0¢ |
Sellers (Offers)
| Price($) | Vol. | No. |
|---|---|---|
| 23.5¢ | 4874 | 1 |
View Market Depth
| Last trade - 16.10pm 18/07/2025 (20 minute delay) ? |
| EIQ (ASX) Chart |